Related Experiment Video
Updated: Aug 4, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Characteristics of Central Retinal Vein Occlusion in African Americans
Sieh Yean Kiew1, George N Thomas2, Akshay S Thomas3
1Singapore National Eye Centre, Singapore.
Insights
African Americans with central retinal vein occlusion (CRVO) experienced worse presenting vision and more risk factors. While final vision was similar, they faced a higher treatment burden and increased risk of complications.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Public Health
Background:
- Central Retinal Vein Occlusion (CRVO) is a significant cause of vision loss.
- Understanding racial disparities in CRVO is crucial for equitable healthcare.
- Previous research has not fully elucidated differences in CRVO characteristics and outcomes among racial groups.
Purpose of the Study:
- To investigate if the clinical presentation and course of central retinal vein occlusion (CRVO) differ between African American patients and other racial groups.
- To identify potential disparities in risk factors, treatment, and outcomes for CRVO in African Americans.
Main Methods:
- A retrospective cohort study was conducted at Duke Eye Center.
- Consecutive patients diagnosed with CRVO were analyzed based on patient-reported race.
- Presenting characteristics, examination findings, treatment, and outcomes were compared across racial groups.
Main Results:
- African American patients with CRVO were older and had higher rates of hypertension, diabetes, and open-angle glaucoma.
- Presenting visual acuity was significantly worse in African American patients.
- Although final visual acuity did not differ, African Americans experienced higher rates of neovascular sequelae and a greater treatment burden in the first year.
Conclusions:
- African Americans with CRVO present with more severe visual impairment and greater systemic/ocular risk factors.
- Treatment-naive African Americans with CRVO incurred a higher treatment burden within the first year.
- These findings highlight potential disparities in CRVO management and outcomes that warrant further investigation.
Purpose:
This article studies whether the characteristics and clinical course of African American patients with central retinal vein occlusion (CRVO) differ from other racial groups.
Methods:
This retrospective cohort study included consecutive patients diagnosed with CRVO at Duke Eye Center, Durham, North Carolina. Presenting characteristics, examination findings, treatment course, and functional and structural outcomes were compared based on patient-reported race.
Results:
A total of 479 patients with CRVO were included (64.7% white, 22.2% African American, 1.7% mixed race, and 11.4% other races). African American patients were older (68.1 vs 64.3 years, P = .049), more likely to be hypertensive (P = .001) and diabetic (P = .000), and had higher rates of open-angle glaucoma (P < .000). Presenting visual acuity (VA) was worse in African Americans (logarithm of the minimum angle of resolution 1.25 vs 0.96, P = .010). There were no significant differences in the proportion of patients requiring panretinal photocoagulation, intravitreal antivascular endothelial growth factor (anti-VEGF), or intravitreal corticosteroid; however, analysis of treatment-naive individuals showed a higher number of anti-VEGF injections in the first year in African Americans. Final VA was not significantly different between groups, but African Americans had higher rates of neovascular sequelae (25.0% vs 11.8%, P = .019; odds ratio, 2.295, P = .088).
Conclusions:
African Americans with CRVO presented with more severe visual impairment and more systemic and ocular risk factors for CRVO. Treatment-naive African Americans had a greater treatment burden during the first year of follow-up.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Angle Closure Glaucoma: Treatment

